Obstetric management of thyroid disease

Obstetrical and Gynecological Survey

Volumn 62, Issue 10, 2007, Pages 680-688

  Rashid, Mumtaz ^a,c   Rashid, Mohammed H ^b  

^a JAMES PAGET UNIVERSITY HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPYRETIC AGENT; ANTITHYROID AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHORIONIC GONADOTROPIN; DEXAMETHASONE; ESMOLOL; GUANETHIDINE; IODINE; LIOTHYRONINE; METHYLPREDNISOLONE; PAGE 684 LEFT COLUMN PAR 3; PHENOBARBITAL; POTASSIUM IODIDE; PROPRANOLOL; PROPYLTHIOURACIL; PROTIRELIN; RESERPINE; SODIUM IODIDE; THIAMAZOLE; THIONAMIDE; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; THYROID HORMONE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE; UNCLASSIFIED DRUG;

ADVERSE OUTCOME; AGRANULOCYTOSIS; ANOREXIA; ARTHRITIS; CLINICAL INDICATOR; DIAGNOSTIC ACCURACY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG ERUPTION; DRUG FEVER; DRUG MECHANISM; EARLY INTERVENTION; ELECTROLYTE BALANCE; FETUS OUTCOME; GESTATIONAL AGE; GRAVES DISEASE; HEART RATE; HEPATITIS; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; INCIDENCE; IODINE DEFICIENCY; MATERNAL CARE; MORBIDITY; NAUSEA; NERVE CELL DIFFERENTIATION; OBSTETRIC CARE; OXYGEN THERAPY; PHYSIOLOGY; POSTPARTUM THYROIDITIS; PREGNANCY OUTCOME; PREGNANCY TEST; PREGNANT WOMAN; PRENATAL SCREENING; PREVALENCE; PROGNOSIS; REVIEW; SCREENING TEST; SMELLING DISORDER; SYMPTOMATOLOGY; TACHYCARDIA; TASTE DISORDER; THROMBOCYTOPENIA; THYROID CANCER; THYROID CRISIS; THYROID DISEASE; THYROID FUNCTION TEST; THYROID GLAND; THYROTOXICOSIS; THYROTROPIN BLOOD LEVEL; UNITED KINGDOM; VASCULITIS;

ADULT; FEMALE; GRAVES DISEASE; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; INFANT; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY COMPLICATIONS, NEOPLASTIC; THYROID CRISIS; THYROID DISEASES; THYROID FUNCTION TESTS; THYROTOXICOSIS; THYROTROPIN; THYROXINE;

EID: 34848842527     PISSN: 00297828     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ogx.0000281558.59184.b5     Document Type: Review

References (44)

1. Brent GA. Maternal thyroid function: interpretation of thyroid function tests in pregnancy. Clin Obstet Gynecol 1997;40:3-15.
2. Glinoer D, Fernandez Soto M, Bourdoux P, et al. Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions. J Clin Endocrinol Metab 1991;73:421-427.
3. Haddow JE, Palomaki GE, Allan WC et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Eng J Med 1999;341:548-555.
4. Pop VJ, Brouwers EP, Vader HL, et al. Maternal hypothroxinaemia during early pregnancy and subsequent child development: a 3 year follow-up study. Clin Endocrinol 2003;59:282-288.
5. Fantz C, Dagogo-Jack S, Ladenson JH, et al. Thyroid function during pregnancy. Clin Chem 1999;45:2250-2258.
6. Hague WM. Pre-existing endocrine disease in relation to pregnancy-thyroid disorders. Current Obstet Gynecol 1999;9:63-68.
7. Bagis T, Gokcel A, Saygili ES. Autoimmune thyroid disease in pregnancy and the postpartum period: relationship to spontaneous abortion. Thyroid 2001;11:1049-1053.
8. Gharib H, Tuttle RM, Baskin HJ, et al. Consensus statement #1. Subclinical thyroid dysfunction: a joint statement on management from the American Association of clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society. Thyroid 2005;15:24-28.
9. Neale D, Burrow G. Thyroid disease in pregnancy. Obstet Gynecol Clin North Am 2004;31:893-905.
10. Allen WC, Haddow JE, Palomaki GE, et al. Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen 2000;7:127-130.
11. Canaris GJ, Manowitz NR, Mayor G, et al. The Colarado thyroid disease prevalence study. Arch Intern Med 2000;160:526-534.
12. Glonoer D, de Nayer P, Bourdoux P, et al. Regulation of maternal thyroid during pregnancy. J Clin Endocrinol Metab 1990;71:276-287.
13. Casey BM, Leveno KJ. Thyroid disease in pregnancy. Obstet Gynecol 2006;108:1283-1292.
14. Dashe JS, Casey BM, Wells CE, et al. Thyroid-stimulating hormone in singleton and twin pregnancy: importance of gestational age-specific reference ranges. Obstet Gynecol 2005;106:753-757.
15. Lazarus JH, Premawardhana LDKE. Screening for thyroid disease in pregnancy. J Clin Pathol 2005;58:449-452.
16. Alvarez-Marfany M, Roman SH, Drexler AJ, et al. Long term prospective study of postpartum thyroid dysfunction in women with insulin dependent diabetes mellitus. J Clin Endocrinol Metab 1994;79:10-16.
17. Kibirige MS, Hutchison S, Owen CJ, Delves HT. Prevalence of maternal dietary iodine insufficiency in the north east of England: implications for the fetus. Arch Dis Child Fetal Neonatal Ed 2004;89:436-439.
18. Weetman AP, McGregor AM. Autoimmune thyroid disease: further development is an understanding. Endocrinol Rev 1994;15:788-830.
19. Alexander EK, Marqusee E, Lawrence J, et al. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med 2004;351:241-249.
20. Woeber KA. Subclinical thyroid dysfunction. Arch Intern Med 1997;157:1065-1068.
21. Casey BM, Dashe JS, Wells E, et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol 2005;105:239-245.
22. Burrow GN, Golden LH. Maternal thyrotoxicosis. Endotext-.com 2002;Chapter 1 Section 5, 1-15.
23. Zimmerman D. Fetal and neonatal hyperthyroidism. Thyroid 1999;9:727-733.
24. Weetman AP. Graves disease. N Engl J Med 2000;343:1236-1248.
25. Luton D, Le Gac I, Vuillard E, et al. Management of Graves' disease during pregnancy: the key role of fetal thyroid gland monitoring. J Clin Endocrinol Metab 2005;90:6093-6098.
26. Mandel SJ, Cooper DS. The use of antithyroid drugs in pregnancy and lactation. J Clin Endocrinol Metab 2001;86:2354-2359.
27. Sheffield JS, Cunningham FG. Thyrotoxicosis and heart failure that complicate pregnancy. Am J Obstet Gynaecol 2004;190:211-217.
28. Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am 1993;22:263-277.
29. Milham S Jr. Scalp defects in infants of mothers treated for hyperthyroidism with methimazole or cabimazole during pregnancy. Teratology 1985;32:321.
30. ACOG practice bulletin. Thyroid disease in pregnancy. Int J Gynaecol Obstet 2002;79:171-180.
31. Fisher DA. Disorders of the thyroid in the newborn and infant. In: Sperling M, ed. Pediatric Endocrinology, 2nd ed. Philadelphia, PA: WB Saunders, 2002:161-185.
32. McKenzie JM, Zakarija M. Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies. Thyroid 1992;2:155-159.
33. Kamishlian A, Mattews N, Gupta A, et al. Different outcomes of neonatal thyroid function after Graves' disease in pregnancy: patient reports and literature review. J Pediatr Endocrinol Metab 2005;18:1357-1363.
34. Goodwin TM, Montoro M, Mestman JH. Transient hyperthyroidism and hyperemesis gravidarum: clinical aspects. Am J Obstet Gynecol 1992;167:648-652.
35. Surks MI, Oritz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004;291:2282-38.
36. Casey BM, Dashe JS, Wells CE, et al. Subclinical hyperthyroidism and pregnancy outcomes. Obstet Gynecol 2006;107:337-341.
37. Amino N, Tada H, Hidaka Y, et al. Postpartum autoimmune thyroid syndrome. Endocr J 2000;47:645-655.
38. Lazarus JH, Ammari F, Oretti R, et al. Clinical aspects of recurrent postpartum thyroiditis. Br J Gen Pract 1997;47:305-308.
39. Muller AF, Drexhage HA, Berghout A. Postpartum thyroiditis and autoimmune thyroiditis in women of hildbearing age: recent insights and consequences for antenatal and postnatal care. Endocr Rev 2001;22:605-630.
40. Lucas A, Pizarro E, Granada ML, et al. Postpartum thyroiditis: epidemiology and clinical evolution in a nonselected population. Thyroid 2000;10:71-77.
41. Moosa M, Mazzaferri EL. Outcome of differentiated thyroid cancer diagnosed in pregnant women. J Clin Endocrinol Metab 1997;82:2862-2866.
42. Schlumberger M, De Vathaire F, Ceccarelli C, et al. Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients. J Nucl Med 1996;37:606-612.
43. McClellan SJ, Francis GL. Thyroid cancer in children, pregnant women, and patients with Graves' disease. Endocrinol Metab Clin North Am 1996;25:27-48.
44. Gruters A, Biebermann H, Krude H. Neonatal thyroid disorders. Horm Res 2003;59:24-29.